The story has been updated to include comments made by company officials during a conference call.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker today reported revenues in the fourth quarter grew 14 percent year over year.

For the quarter ended Dec. 31, 2011, the company took in $475.1 million, up from $416.1 million a year ago, beating Wall Street estimates of $468.6.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.